Oppenheimer (NYSE:OPY) Share Price Crosses Above Two Hundred Day Moving Average – Time to Sell?

Oppenheimer Holdings, Inc. (NYSE:OPYGet Free Report) passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $70.87 and traded as high as $74.49. Oppenheimer shares last traded at $74.3210, with a volume of 22,725 shares.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Weiss Ratings restated a “buy (b-)” rating on shares of Oppenheimer in a report on Wednesday, October 8th. Wall Street Zen lowered Oppenheimer from a “strong-buy” rating to a “buy” rating in a research report on Saturday, November 8th. One research analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, Oppenheimer has a consensus rating of “Buy”.

Get Our Latest Analysis on Oppenheimer

Oppenheimer Price Performance

The firm has a 50-day moving average of $70.09 and a 200 day moving average of $70.87. The stock has a market capitalization of $781.86 million, a price-to-earnings ratio of 9.98 and a beta of 1.17.

Oppenheimer (NYSE:OPYGet Free Report) last announced its quarterly earnings data on Friday, October 31st. The financial services provider reported $1.90 earnings per share (EPS) for the quarter. The company had revenue of $401.94 million for the quarter. Oppenheimer had a return on equity of 9.58% and a net margin of 5.50%.

Oppenheimer Dividend Announcement

The company also recently disclosed a special dividend, which will be paid on Friday, January 9th. Stockholders of record on Friday, December 26th will be given a $1.00 dividend. The ex-dividend date of this dividend is Friday, December 26th. Oppenheimer’s dividend payout ratio (DPR) is 9.66%.

Institutional Investors Weigh In On Oppenheimer

Hedge funds have recently bought and sold shares of the company. Dimensional Fund Advisors LP increased its position in Oppenheimer by 0.6% during the third quarter. Dimensional Fund Advisors LP now owns 493,218 shares of the financial services provider’s stock worth $36,456,000 after buying an additional 2,911 shares during the last quarter. Vanguard Group Inc. lifted its position in shares of Oppenheimer by 2.5% in the third quarter. Vanguard Group Inc. now owns 426,033 shares of the financial services provider’s stock valued at $31,488,000 after buying an additional 10,345 shares during the last quarter. American Century Companies Inc. boosted its stake in shares of Oppenheimer by 17.3% during the 3rd quarter. American Century Companies Inc. now owns 299,211 shares of the financial services provider’s stock worth $22,115,000 after acquiring an additional 44,145 shares during the period. Royce & Associates LP increased its holdings in shares of Oppenheimer by 18.0% during the 3rd quarter. Royce & Associates LP now owns 112,404 shares of the financial services provider’s stock worth $8,308,000 after acquiring an additional 17,122 shares during the last quarter. Finally, Boston Partners raised its stake in Oppenheimer by 11.7% in the 3rd quarter. Boston Partners now owns 78,941 shares of the financial services provider’s stock valued at $5,835,000 after acquiring an additional 8,250 shares during the period. 32.26% of the stock is currently owned by institutional investors and hedge funds.

About Oppenheimer

(Get Free Report)

Oppenheimer & Co Inc is a full-service investment bank and wealth management firm headquartered in New York City. Founded in the mid-20th century, the company provides a broad array of financial services to individual, institutional and corporate clients. Its core competencies include equity and fixed-income research, institutional sales and trading, underwriting and merger-and-acquisition advisory.

In the wealth management segment, Oppenheimer offers tailored investment solutions, comprehensive financial planning and retirement strategies.

Further Reading

Receive News & Ratings for Oppenheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oppenheimer and related companies with MarketBeat.com's FREE daily email newsletter.